A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia
J. Clin. Invest. Björn de Rijke, et al. 115:3506 doi:10.1172/JCI24832 [Go to this article.]

Table 2
Expression profile of candidate genes located between marker D17S1845 and D17S1876 on chromosome 17p13.2